Veeva Systems has expanded its leadership team across product management and cloud software development.

“We have a significant opportunity to help the industry overcome current limitations and better manage the complexity of global trials,” said Peter Gassner, founder and chief executive officer of Veeva Systems. “We’re deepening the bench on our world-class clinical team with talented leaders that bring strong technology and life sciences background to Veeva. Our balance of industry expertise and cloud software knowledge puts us in a unique position to be a strategic partner to life sciences.”

Henry Levy has been named chief strategy officer to lead market strategy and strategic relationships with customers and partners in multiple areas, including clinical, as well as various industry collaborations. Mr. Levy has nearly 25 years of experience in biopharmaceutical industry. Previously, he ran client development and commercial services at PPD, and was head of Accenture’s global life sciences R&D practice.

Jill Johnston was appointed vice president, Veeva Vault Clinical, responsible for leading the development of clinical operations products and market strategy. She has more than 20 years of experience in clinical operations, pharmaceutical efficiency, and transformation initiatives across Phase I-IV. Prior to Veeva, she held a variety of senior leadership roles in clinical operations, project management, and Six Sigma at Covance.

Brian Longo will serve as senior vice president and general manager, Veeva Vault EDC . For the past 10 years, Mr. Longo has architected industry-specific cloud solutions for drug discovery, medical affairs, and commercial. He leads the development of Vault EDC and Vault eSource, delivering the technology solutions aimed at improving speed and data quality, and reducing complexity in clinical trials.

Richard Young was named  vice president, Veeva Vault EDC. Mr. Young has nearly 25 years of experience in data management, clinical solutions, and advanced clinical strategies. He has held roles at Medidata, where he focused on adaptive trials, risk-based monitoring, mHealth, and big data, as well as operational roles at leading pharma and CRO organizations, including GlaxoWellcome, Novo Nordisk, and PAREXEL.  

Drew Garty was named vice president, product management, Veeva Vault EDC. Mr. Garty has 20 years of pharmaceutical technology experience, including extensive experience in clinical system architecture, design, and development, including EDC. He is responsible for developing and implementing innovative technology solutions as part of the Veeva Vault Clinical Suite, including Vault EDC and Vault eSource. He previously spent the majority of his career at PAREXEL, where he led the institutionalization of EDC and development of solutions such as risk-based monitoring.

Michelle Marlborough will serve as vice president, product management, Veeva Vault CTMS – Ms. Marlborough is responsible for the development of Veeva Vault CTMS. She brings 20 years of experience transforming clinical trials through innovative technology and analytics. She previously served as vice president of product strategy at Medidata and held data management roles at leading pharmaceutical companies, including GSK and AstraZeneca.